Literature DB >> 22652399

Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness.

Sarah Kidd1, Bassirou Ouedraogo, Chantal Kambire, Jean Ludovic Kambou, Huong McLean, Preeta K Kutty, Serigne Ndiaye, Amadou Fall, Mary Alleman, Kathleen Wannemuehler, Balcha Masresha, James L Goodson, Amra Uzicanin.   

Abstract

OBJECTIVE: We investigated a large measles outbreak that occurred in 2009 in Burkina Faso in order to describe the epidemic, assess risk factors associated with measles, and estimate measles vaccine effectiveness.
METHODS: We reviewed national surveillance and measles vaccine coverage data, and conducted a case-control study in three geographic areas. Case-patients were randomly selected from the national case-based measles surveillance database or, when a case-patient could not be traced, were persons in the same community who experienced an illness meeting the WHO measles clinical case definition. Controls were matched to the same age stratum (age 1-14 years or age 15-30 years) and community as case-patients. Risk factors were assessed using conditional logistic regression.
RESULTS: Lack of measles vaccination was the main risk factor for measles in all three geographic areas for children aged 1-14 years (adjusted matched odds ratio [aMOR] [95% confidence interval (CI)], 19.4 [2.4-155.9], 5.9 [1.6-21.5], and 6.4 [1.8-23.0] in Bogodogo, Zorgho, and Sahel, respectively) and persons aged 15-30 years (aMOR [95% CI], 3.2 [1.1-9.7], 19.7 [3.3-infinity], 8.0 [1.8-34.8] in Bogodogo, Zorgho, and Sahel, respectively). Among children aged 1-14 years, VE of any measles vaccination prior to 2009 was 94% (95% CI, 45-99%) in Bogodogo, 87% (95% CI, 37-97%) in Zorgho, and 84% (95% CI, 41-96%) in Sahel. Main reasons for not receiving measles vaccination were lack of knowledge about vaccination campaigns or need for measles vaccination and absence during vaccination outreach or campaign activities.
CONCLUSION: These results emphasize the need for improved strategies to reduce missed opportunities for vaccination and achieve high vaccination coverage nationwide in order to prevent large measles outbreaks and to continue progress toward measles mortality reduction. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652399      PMCID: PMC6743076          DOI: 10.1016/j.vaccine.2012.05.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.

Authors:  Sarah A Meyer; Jean Ludovic Kambou; Amanda Cohn; James L Goodson; Brendan Flannery; Isaïe Medah; Nancy Messonnier; Ryan Novak; Fabien Diomande; Mamoudou H Djingarey; Thomas A Clark; Issaka Yameogo; Amadou Fall; Kathleen Wannemuehler
Journal:  Vaccine       Date:  2015-01-28       Impact factor: 3.641

2.  Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.

Authors:  Heather Melissa Scobie; Benoît Kebela Ilunga; Audry Mulumba; Calixte Shidi; Tiekoura Coulibaly; Ricardo Obama; Jean-Jacques Muyembe Tamfum; Elisabeth Pukuta Simbu; Sheilagh Brigitte Smit; Balcha Masresha; Robert Tyrrell Perry; Mary Margaret Alleman; Katrina Kretsinger; James Goodson
Journal:  Pan Afr Med J       Date:  2015-05-15

3.  The effects of maternal immunity and age structure on population immunity to measles.

Authors:  A McKee; M J Ferrari; K Shea
Journal:  Theor Ecol       Date:  2015-05       Impact factor: 1.432

4.  Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control.

Authors:  M J Ferrari; B T Grenfell; P M Strebel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

5.  Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases.

Authors:  Petra Klepac; C Jessica E Metcalf; Angela R McLean; Katie Hampson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

6.  Measuring populations to improve vaccination coverage.

Authors:  Nita Bharti; Ali Djibo; Andrew J Tatem; Bryan T Grenfell; Matthew J Ferrari
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

7.  Optimal vaccine schedules to maintain measles elimination with a two-dose routine policy.

Authors:  A McKEE; K Shea; M J Ferrari
Journal:  Epidemiol Infect       Date:  2016-10-20       Impact factor: 2.451

8.  Demographic transition and the dynamics of measles in six provinces in China: A modeling study.

Authors:  Sheng Li; Chao Ma; Lixin Hao; Qiru Su; Zhijie An; Fubao Ma; Shuyun Xie; Aiqiang Xu; Yanyang Zhang; Zhengrong Ding; Hui Li; Lisa Cairns; Huaqing Wang; Huiming Luo; Ning Wang; Li Li; Matthew J Ferrari
Journal:  PLoS Med       Date:  2017-04-04       Impact factor: 11.069

9.  Revealing Measles Outbreak Risk With a Nested Immunoglobulin G Serosurvey in Madagascar.

Authors:  Amy K Winter; Amy P Wesolowski; Keitly J Mensah; Miora Bruna Ramamonjiharisoa; Andrianmasina Herivelo Randriamanantena; Richter Razafindratsimandresy; Simon Cauchemez; Justin Lessler; Matt J Ferrari; C Jess E Metcalf; Jean-Michel Héraud
Journal:  Am J Epidemiol       Date:  2018-10-01       Impact factor: 4.897

10.  Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.

Authors:  Bishwa B Adhikari; James L Goodson; Susan Y Chu; Paul A Rota; Martin I Meltzer
Journal:  Drugs R D       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.